Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07170761Active Not Recruiting

Biomarkers and Event Patterns of Vascular Disease in Hemodialysis

Role: collaborator

NCT03087773Phase 3Completed

Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction

Role: collaborator

NCT03171909Unknown

Austrian Registry on the Outcome of Monochorionic Pregnancies

Role: collaborator

NCT01512030Completed

Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study

Role: lead

NCT01017718Completed

Nerve Conduction Velocity in Diabetic Children

Role: lead

All 5 trials loaded